Indazole compounds as 5-HT4 receptor agonists
The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions co...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
17.08.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxytryptamine 4 (5-HT4) receptor agonists
本发明涉及式(I)的新吲唑化合物,包括其立体异构体及其可药用盐,其中R是烷基或环烷基;(式II)本发明还涉及制备这样的化合物的方法和包含这样的化合物的药物组合物。本发明的化合物可用于治疗与5-羟基-色胺4(5-HT)受体激动剂相关的多种疾病。 |
---|---|
AbstractList | The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxytryptamine 4 (5-HT4) receptor agonists
本发明涉及式(I)的新吲唑化合物,包括其立体异构体及其可药用盐,其中R是烷基或环烷基;(式II)本发明还涉及制备这样的化合物的方法和包含这样的化合物的药物组合物。本发明的化合物可用于治疗与5-羟基-色胺4(5-HT)受体激动剂相关的多种疾病。 |
Author | Nirogi Ramakrishna Mohammed Abdul Rasheed Gagginapally Shankar Reddy Shinde Anil Karbhari Jasti Venkateswarlu |
Author_xml | – fullname: Jasti Venkateswarlu – fullname: Mohammed Abdul Rasheed – fullname: Gagginapally Shankar Reddy – fullname: Shinde Anil Karbhari – fullname: Nirogi Ramakrishna |
BookMark | eNrjYmDJy89L5WTQ9cxLSazKz0lVSM7PLcgvzUspVkgsVjDV9QgxUShKTU4tKMkvUkhMz8_LLC4p5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hgamFubGlkYGjsbEqAEAdzUrWA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 作为5-HT4受体激动剂的吲唑化合物 |
ExternalDocumentID | CN105873920A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN105873920A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:47:30 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN105873920A3 |
Notes | Application Number: CN201480068132 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160817&DB=EPODOC&CC=CN&NR=105873920A |
ParticipantIDs | epo_espacenet_CN105873920A |
PublicationCentury | 2000 |
PublicationDate | 20160817 |
PublicationDateYYYYMMDD | 2016-08-17 |
PublicationDate_xml | – month: 08 year: 2016 text: 20160817 day: 17 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | Suven Life Sciences Ltd |
RelatedCompanies_xml | – name: Suven Life Sciences Ltd |
Score | 3.1644037 |
Snippet | The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Indazole compounds as 5-HT4 receptor agonists |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160817&DB=EPODOC&locale=&CC=CN&NR=105873920A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNp6LzBxGkb8WVNkv7UMSlLVVYN6TK3kbTplMRW2xF2F_vpXTOF30LCSS5gy933-VyAbgyqZOjV2vrTGQUCUpKdTGkiU6FQVPDYPlAqnjHOBqGj9b9jM468Lp6C9PUCf1qiiMiolLEe92c1-U6iOU1uZXVtXjBruImiF1Pa9mxMUQLxzRv5PrTiTfhGucuj7ToAX1dajP0BQa3G7CJbjRTaPCfRupVSvnbpAR7sDXF2d7rfegsn3uww1c_r_Vge9xeeGOzxV51APodsudl8SaJSgNXvyFVJKkI1cPYInhuyRLpM0kWhaqFWx3CZeDHPNRx3fmPkHMerbdoHkEXyb88BpKadpbKzLRywSxkc45pUUcIFEDYeWanJ9D_e57-f4OnsKsUpuKjBjuDbv3xKc_RwNbiotHMN-MkfmQ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTmXOrwrSt-JKm6V9KOLSjU7XbkiVvY0lTf1AbLEVYX-9l7I5X_QtJHBJDu7jd8ndAVxaxE3Rq3UMyhOCAEUQg3fJ3CDcJMI0adqRKt4RRt3gwb6dkmkNXle5MFWd0K-qOCJKlEB5Lyt9na-DWH71t7K44i84lV0PYs_Xl-jY7KKFo7rf8_qTsT9mOmMei_ToHn1d4lD0BTo3G7CJLjZV0tB_7KmslPy3SRnswtYEqb2Xe1BbPDehwVad15qwHS4fvHG4lL1iH4whoudF9iY19Q1cdUMqtHmhESOIbQ31lswRPmvzp0zVwi0O4GLQj1lg4L6zn0vOWLQ-onUIdQT_sgWasJxEyMSyU05tRHOuZROXc0Iod9LEEUfQ_ptO-7_Fc2gEcTiajYbR3THsKOapWKlJT6BefnzKUzS2JT-ruPQN-zqBVw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Indazole+compounds+as+5-HT4+receptor+agonists&rft.inventor=Jasti+Venkateswarlu&rft.inventor=Mohammed+Abdul+Rasheed&rft.inventor=Gagginapally+Shankar+Reddy&rft.inventor=Shinde+Anil+Karbhari&rft.inventor=Nirogi+Ramakrishna&rft.date=2016-08-17&rft.externalDBID=A&rft.externalDocID=CN105873920A |